(Total Views: 942)
Posted On: 02/08/2021 3:43:48 PM
Post# of 145247
It has a unique MOA -
https://en.wikipedia.org/wiki/Brilacidin
It has had some clinical success treating oral mucositis and ABSSSI. I'm not sure how much, but it was significant.
https://finance.yahoo.com/quote/IPIX/profile?p=IPIX
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It develops Brilacidin, a lead drug compound for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.
And the government is involved -
http://www.ipharminc.com/press-release/2020/6...herapeutic
http://www.ipharminc.com/press-release
http://www.ipharminc.com/press-release/2020/8...ro-testing
https://en.wikipedia.org/wiki/Brilacidin
It has had some clinical success treating oral mucositis and ABSSSI. I'm not sure how much, but it was significant.
https://finance.yahoo.com/quote/IPIX/profile?p=IPIX
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It develops Brilacidin, a lead drug compound for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.
And the government is involved -
http://www.ipharminc.com/press-release/2020/6...herapeutic
http://www.ipharminc.com/press-release
http://www.ipharminc.com/press-release/2020/8...ro-testing
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)